blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3009448

EP3009448 - SINGLE CHAIN FC POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.07.2018
Database last updated on 26.03.2026
FormerThe patent has been granted
Status updated on  11.08.2017
FormerGrant of patent is intended
Status updated on  23.03.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY		published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
UCB Biopharma SPRL
Allée de la Recherche 60
1070 Brussels / BE
[2016/16]
Inventor(s)01 / LAWSON, Alastair David Griffiths
c/o UCB Celltech, IPD, 208 Bath Road
Slough, Berkshire, SL1 3WE / GB
02 / STEPHENS, Paul Edward
c/o UCB Celltech, IPD, 208 Bath Road
Slough, Berkshire, SL1 3WE / GB
 [2016/16]
Representative(s)UCB Intellectual Property
c/o UCB Celltech
IP Department
208 Bath Road
Slough, Berkshire SL1 3WE / GB
[2017/37]
Former [2016/16]Blanchard, Amanda Jane
UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
Application number, filing date15190901.724.07.2007
[2016/16]
Priority number, dateGB2006001478025.07.2006         Original published format: GB 0614780
[2016/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3009448
Date:20.04.2016
Language:EN
[2016/16]
Type: B1 Patent specification 
No.:EP3009448
Date:13.09.2017
Language:EN
[2017/37]
Search report(s)(Supplementary) European search report - dispatched on:EP09.03.2016
ClassificationIPC:C07K16/00
[2016/16]
CPC:
C07K16/00 (EP,US); A61P1/02 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P1/18 (EP); A61P11/06 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P31/12 (EP); A61P33/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P7/02 (EP); A61P9/10 (EP);
A61P9/14 (EP); C07K2317/52 (EP,US); C07K2317/734 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/48]
Former [2016/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL20.10.2016
BA20.10.2016
HR20.10.2016
MK20.10.2016
RS20.10.2016
TitleGerman:EINKETTIGE FC-POLYPEPTIDE[2016/16]
English:SINGLE CHAIN FC POLYPEPTIDES[2016/16]
French:POLYPEPTIDES FC À CHAÎNE SIMPLE[2016/16]
Examination procedure20.10.2016Amendment by applicant (claims and/or description)
20.10.2016Examination requested  [2016/48]
24.03.2017Communication of intention to grant the patent
24.07.2017Fee for grant paid
24.07.2017Fee for publishing/printing paid
24.07.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07789062.2  / EP2046832
Opposition(s)14.06.2018No opposition filed within time limit [2018/34]
Fees paidRenewal fee
22.02.2016Renewal fee patent year 03
22.02.2016Renewal fee patent year 04
22.02.2016Renewal fee patent year 05
22.02.2016Renewal fee patent year 06
22.02.2016Renewal fee patent year 07
22.02.2016Renewal fee patent year 08
22.02.2016Renewal fee patent year 09
01.08.2016Renewal fee patent year 10
31.07.2017Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.07.2007
AT13.09.2017
CY13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
NL13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
[2020/32]
Former [2020/30]HU24.07.2007
AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
NL13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2020/28]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
NL13.09.2017
PL13.09.2017
PT13.09.2017
RO13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2019/15]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
MC13.09.2017
NL13.09.2017
PL13.09.2017
RO13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/52]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
NL13.09.2017
PL13.09.2017
RO13.09.2017
SE13.09.2017
SI13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/35]AT13.09.2017
CZ13.09.2017
DK13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
NL13.09.2017
PL13.09.2017
RO13.09.2017
SE13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/23]AT13.09.2017
CZ13.09.2017
EE13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
NL13.09.2017
PL13.09.2017
RO13.09.2017
SE13.09.2017
SK13.09.2017
BG13.12.2017
GR14.12.2017
IS13.01.2018
Former [2018/21]CZ13.09.2017
FI13.09.2017
LT13.09.2017
LV13.09.2017
NL13.09.2017
SE13.09.2017
BG13.12.2017
GR14.12.2017
Former [2018/15]FI13.09.2017
LT13.09.2017
LV13.09.2017
NL13.09.2017
SE13.09.2017
BG13.12.2017
GR14.12.2017
Former [2018/12]FI13.09.2017
LT13.09.2017
LV13.09.2017
SE13.09.2017
BG13.12.2017
GR14.12.2017
Former [2018/09]FI13.09.2017
LT13.09.2017
SE13.09.2017
Former [2018/08]FI13.09.2017
LT13.09.2017
Former [2018/07]LT13.09.2017
Documents cited:Search[A] WO2005077981  (XENCOR INC et al.)
 [A] WO2005001025  (SYNTONIX INC et al.)
 [A] US6165745  (WARD E SALLY et al.)
 [A]   GREENWOOD J ET AL: "ENGINEERING MULTIPLE-DOMAIN FORMS OF THE THERAPEUTIC ANTIBODY CAMPATH-1H: EFFECTS ON COMPLEMENT LYSIS", THERAPEUTIC IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBL. LONDON, GB, vol. 1, no. 5, October 1994 (1994-10-01), pages 247 - 255, XP009059035, ISSN: 0967-0149
 [A]   LOW S C ET AL: "Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis", HUMAN REPRODUCTION (OXFORD), vol. 20, no. 7, July 2005 (2005-07-01), pages 1805 - 1813, XP002455704, ISSN: 0268-1161

DOI:   http://dx.doi.org/10.1093/humrep/deh896
 [A]   BITONTI A J ET AL: "Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 26, 29 June 2004 (2004-06-29), pages 9763 - 9768, XP003008495, ISSN: 0027-8424

DOI:   http://dx.doi.org/10.1073/pnas.0403235101
 [A]   DUMONT JENNIFER A ET AL: "MONOMERIC FC FUSIONS: IMPACT ON PHARMACOKINETIC AND BIOLOGICAL ACTIVITY OF PROTEIN THERAPEUTICS", BIODRUGS, AUCKLAND, NZ, vol. 20, no. 3, 1 May 2006 (2006-05-01), pages 151 - 160, XP009082835, ISSN: 1173-8804

DOI:   http://dx.doi.org/10.2165/00063030-200620030-00002
by applicantWO2005001025
 WO2005077981
 WO2005017148
 WO2005010125
 US5677425
 WO9915549
 WO9825971
 WO2005003171
 WO2005003169
 WO2005003170
 US5585089
 WO9202551
 WO2004051268
 WO2004106377
 US4816397
 US6331415
 WO9109967
 US5219996
 WO9222583
 US4741900
 WO9723613
 WO9900494
 WO9957268
 WO0063374
 WO0063373
 WO0063372
 WO0132709
 WO0132866
 WO0132867
 WO0233101
 WO2004039840
 WO9820734
   DUMONT ET AL., BIODRUGS, vol. 20, no. 3, 2006, pages 151 - 160
   HAYDEN ET AL., THERAPEUTIC IMMUNOLOGY, vol. 1, 1994, pages 3 - 15
   GLENNIE; STEVENSON, NATURE, vol. 295, 1982, pages 712 - 713
   MICHAELSEN; NATVIG, SCAND. J. IMMUNOLOGY, vol. 2, 1973, pages 299 - 312
   MICHAELSEN; NATVIG, SCAND. J. IMMUNOLOGY, vol. 1, 1972, pages 255 - 268
   WINES; EASTERBROOK-SMITH, MOLECULAR IMMUNOLOGY, vol. 28, no. 8, 1991, pages 855 - 863
   KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1987, US DEPARTMENT OF HEALTH AND HUMAN SERVICES
   LESK, A.M.: "Computational Molecular Biology", 1988, OXFORD UNIVERSITY PRESS
   SMITH, D.W.: "Biocomputing. Informatics and Genome Projects", 1993, ACADEMIC PRESS
   GRIFFIN, A.M., AND GRIFFIN, H.G.: "Computer Analysis of Sequence Data", 1994, HUMANA PRESS
   HEINJE, G.: "Sequence Analysis in Molecular Biology", 1987, ACADEMIC PRESS
   GRIBSKOV, M. AND DEVEREUX, J.: "Sequence Analysis Primer", 1991, M STOCKTON PRESS
   IDUSOGIE ET AL., JOURNAL OF IMMUNOLOGY, vol. 164, 2000, pages 4178 - 4184
   SHIELDS ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 9, 2001, pages 6591 - 6604
   ANGAL ET AL., MOLECULAR IMMUNOLOGY, vol. 30, no. 1, 1993, pages 105 - 108
   NYGREN; UHLEN, CURRENT OPINION IN STRUCTURAL BIOLOGY, vol. 7, 1997, pages 463 - 469
   ADAIR; LAWSON: "Therapeutic antibodies", DRUG DESIGN REVIEWS - ONLINE, vol. 2, no. 3, 2005, pages 209 - 217
   KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495 - 497
   KOZBOR ET AL., IMMUNOLOGY TODAY, vol. 4, 1983, pages 72
   COLE ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, ALAN R. LISS, INC., pages: 77 - 96
   BABCOOK, J. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, no. 15, 1996, pages 7843 - 7848
   WARD ET AL., NATURE, vol. 341, 1989, pages 544
   ORLANDI ET AL., PROC.NATLACAD.SCI. USA, vol. 86, 1989, pages 3833
   RIECHMANN ET AL., NATURE, vol. 322, 1988, pages 323
   BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423
   MOUNTAIN; ADAIR, BIOTECHNOL. GENET. ENG. REV, vol. 10, 1992, pages 1 - 142
   VERMA ET AL., JOURNAL OF IMMUNOLOGICAL METHODS, vol. 216, 1998, pages 165 - 181
   F. M. AUSUBEL: "Current Protocols in Molecular Biology", 1999, WILEY INTERSCIENCE
   "Maniatis Manual", COLD SPRING HARBOR PUBLISHING
   "Remington's Pharmaceutical Sciences", 1991, MACK PUBLISHING COMPANY
   WHITTLE ET AL., PROTEIN ENG., vol. 1, no. 6, 1987, pages 499 - 505
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.